AzTrials
AzTrials

OsteoarthritisTKANCT03424174

Clinical Outcome and Cytokine Expression After TKA

A study testing Coated Total Knee Arthroplasty and Standard Total Knee Arthroplasty in people with Osteoarthritis, run by Technische Universität Dresden at 1 site in Germany.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoarthritis
What is being tested?
Coated Total Knee Arthroplasty and Standard Total Knee Arthroplasty
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteGermany
Study dates
4 Jan 2017to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary and secondary osteoarthritis
  • understanding of german language

Who cannot join

  • necessity of constrained TKA
  • existence of other joint implants

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden

    Dresden, Saxony, 01307

Other trials in Germany

About this study

Official title: Clinical Outcome and Cytokine Expression in Blood After Coated in Comparison to Uncoated TKA

Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results

Read the detailed description

Comparison of coated and uncoated TKA with regard to cytokine expression and clinical results at 3 months, 1 year and 3 years after surgery

Conditions
Osteoarthritis
Being tested
Coated Total Knee Arthroplasty, Standard Total Knee Arthroplasty
Keywords
TKA, cytokine, coating
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coated Total Knee ArthroplastyDevice

    Implantation coated Total Knee Arthroplasty

  • Standard Total Knee ArthroplastyDevice

    Implantation StandardTotal Knee Arthroplasty

Study groups in NCT03424174
Study groupRoleWhat they receive
Coated Total Knee ArthroplastyExperimentalImplantation coated Total Knee Arthroplasty
Receives: Device: Coated Total Knee Arthroplasty
Standard Total Knee ArthroplastyActive comparatorImplantation Standard Total Knee Arthroplasty
Receives: Device: Standard Total Knee Arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cytokine expression

    Changes of cytokine expression 1 and 3 years after surgery compared to pre-op

    Measured: pre-op, 1 and 3 years post-op

Secondary outcomes (4)
  1. Function assessed with Knee Society Score

    Knee Society Score (0 - 100 points, best 100)

    Measured: pre-op, 3 months, 1 and 3 years post-op

  2. Patient reported outcome assessed with Oxford Knee Score

    Oxford Knee Score (0 - 48 points, best 48)

    Measured: pre-op, 3 months, 1 and 3 years post-op

  3. Quality of life assessed with EQ 5D

    EQ 5D Index (0 - 1.0, best 1.0)

    Measured: pre-op, 3 months, 1 and 3 years post-op

  4. Activity assessed with UCLA activity score

    UCLA activity score (0 - 10 points, best 10)

    Measured: pre-op, 3 months, 1 and 3 years post-op

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2018
  2. Study start4 Jan 2017
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03424174
Sponsor's protocol ID
TKA cytokine
Acronym
TKA
Status last verified
Aug 2024
First submitted
17 Mar 2016
Last updated
7 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
Individual data sharing
No

Publications

  • Tille E, Beyer F, Lutzner C, Postler A, Thomas P, Summer B, Lutzner J. No difference in patient reported outcome and inflammatory response after coated and uncoated total knee arthroplasty - a randomized controlled study. BMC Musculoskelet Disord. 2023 Dec 14;24(1):968. doi: 10.1186/s12891-023-07061-x.

    PubMed 38098024

Questions about this trial

What is this clinical trial studying?

A study testing Coated Total Knee Arthroplasty and Standard Total Knee Arthroplasty in people with Osteoarthritis, run by Technische Universität Dresden at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cytokine expression (time frame: pre-op, 1 and 3 years post-op). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03424174, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in